Your Messages Inbox
Your Article Summary
See Latest ArticlesBoston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
Boston Scientific, 09/30/09
Boston Scientific Corporation announced the settlement of more than a dozen lawsuits involving Johnson & Johnson, including the Palmaz–NIR suit. All the disputes involved intellectual property in the interventional cardiology arena. In connection with the settlement, Boston Scientific will make a payment of $716 million to Johnson & Johnson. The settlement payment is within Boston Scientific's existing reserve for the Palmaz–NIR suit and will be made from existing cash on hand.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Personalized Medicine Market To Grow 11% Annually
PharmExec, 12/16/09
Generic drugs dominate market, look to expand into biologics
Formulary , 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09
Article Search
Sponsor